No abstract available
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aged
-
Aged, 80 and over
-
Anti-Bacterial Agents / adverse effects
-
Anti-Bacterial Agents / pharmacology
-
Anti-Bacterial Agents / therapeutic use*
-
Azabicyclo Compounds / adverse effects
-
Azabicyclo Compounds / therapeutic use*
-
Aztreonam / adverse effects
-
Aztreonam / therapeutic use*
-
Ceftazidime / adverse effects
-
Ceftazidime / therapeutic use*
-
Cross Infection / drug therapy
-
Cross Infection / epidemiology
-
Cross Infection / microbiology
-
Disease Outbreaks
-
Drug Combinations
-
Drug Therapy, Combination / adverse effects
-
Drug Therapy, Combination / methods
-
Drug-Related Side Effects and Adverse Reactions / epidemiology
-
Female
-
Hospitals
-
Humans
-
Klebsiella Infections / drug therapy*
-
Klebsiella Infections / epidemiology
-
Klebsiella Infections / microbiology
-
Klebsiella pneumoniae / enzymology*
-
Klebsiella pneumoniae / genetics
-
Klebsiella pneumoniae / isolation & purification
-
Male
-
Microbial Sensitivity Tests
-
Middle Aged
-
Retrospective Studies
-
Spain / epidemiology
-
Treatment Outcome
-
beta-Lactam Resistance*
-
beta-Lactamase Inhibitors / adverse effects
-
beta-Lactamase Inhibitors / therapeutic use*
-
beta-Lactamases / genetics
Substances
-
Anti-Bacterial Agents
-
Azabicyclo Compounds
-
Drug Combinations
-
avibactam, ceftazidime drug combination
-
beta-Lactamase Inhibitors
-
Ceftazidime
-
beta-lactamase CTX-M-15
-
beta-Lactamases
-
beta-lactamase NDM-1
-
oxacillinase
-
Aztreonam